| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2701df74f934fcfb4d51bf5421c70a9 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 |
| filingDate |
2012-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_499db578446acf2fce64fc8a98902804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f35cba1fe5771b7075435a80ac8114d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4923798e8487648cf6debabf64b4c2f4 |
| publicationDate |
2013-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-103450220-A |
| titleOfInvention |
A novel nitroimidazole compound and its use in pharmacy |
| abstract |
The invention relates to a class of novel nitroimidazole compounds, a preparation method and application thereof. Specifically, the present invention relates to a class of nitroimidazole compounds represented by formula (I) and a preparation method thereof, as well as compounds of formula (I) and pharmaceutically acceptable salts thereof in the preparation and treatment of diseases related to infections caused by Mycobacterium tuberculosis. Use in disease medicine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112300192-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110272332-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017537133-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110483549-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110483549-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112300192-B |
| priorityDate |
2012-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |